Nuclear translocation of insulin receptor substrate-1 by the simian virus 40 T antigen and the activated type 1 insulin-like growth factor receptor
- PMID: 12063262
- DOI: 10.1074/jbc.M204658200
Nuclear translocation of insulin receptor substrate-1 by the simian virus 40 T antigen and the activated type 1 insulin-like growth factor receptor
Abstract
32D cells are a murine hemopoietic cell line that undergoes apoptosis upon withdrawal of interleukin-3 (IL-3) from the medium. 32D cells have low levels of the type 1 insulin-like growth factor (IGF-I) receptor and do not express insulin receptor substrate-1 (IRS-1) or IRS-2. Ectopic expression of IRS-1 delays apoptosis but cannot rescue 32D cells from IL-3 dependence. In 32D/IRS-1 cells, IRS-1 is detectable, as expected, in the cytosol/membrane compartment. The SV40 large T antigen is a nuclear protein that, by itself, also fails to protect 32D cells from apoptosis. Co-expression of IRS-1 with the SV40 T antigen in 32D cells results in nuclear translocation of IRS-1 and survival after IL-3 withdrawal. Expression of a human IGF-I receptor in 32D/IRS-1 cells also results in nuclear translocation of IRS-1 and IL-3 independence. The phosphotyrosine-binding domain, but not the pleckstrin domain, is necessary for IRS-1 nuclear translocation. Nuclear translocation of IRS-1 was confirmed in mouse embryo fibroblasts. These results suggest possible new roles for nuclear IRS-1 in IGF-I-mediated growth and anti-apoptotic signaling.
Similar articles
-
Transformation by the simian virus 40 T antigen is regulated by IGF-I receptor and IRS-1 signaling.Oncogene. 2006 Jan 5;25(1):32-42. doi: 10.1038/sj.onc.1209013. Oncogene. 2006. PMID: 16170362
-
Nuclear translocation of insulin receptor substrate-1 by oncogenes and Igf-I. Effect on ribosomal RNA synthesis.J Biol Chem. 2002 Nov 15;277(46):44357-65. doi: 10.1074/jbc.M208001200. Epub 2002 Aug 28. J Biol Chem. 2002. PMID: 12202493
-
Insulin-like growth factor I receptor signaling and nuclear translocation of insulin receptor substrates 1 and 2.Mol Endocrinol. 2003 Mar;17(3):472-86. doi: 10.1210/me.2002-0276. Epub 2002 Dec 6. Mol Endocrinol. 2003. PMID: 12554758
-
T-antigen of human polyomavirus JC cooperates withIGF-IR signaling system in cerebellar tumors of the childhood-medulloblastomas.Anticancer Res. 2003 May-Jun;23(3A):2035-41. Anticancer Res. 2003. PMID: 12894576 Review.
-
Nuclear IRS-1 and cancer.J Cell Physiol. 2012 Aug;227(8):2992-3000. doi: 10.1002/jcp.24019. J Cell Physiol. 2012. PMID: 22454254 Free PMC article. Review.
Cited by
-
IGF-1R targeting in cancer - does sub-cellular localization matter?J Exp Clin Cancer Res. 2023 Oct 20;42(1):273. doi: 10.1186/s13046-023-02850-7. J Exp Clin Cancer Res. 2023. PMID: 37858153 Free PMC article. Review.
-
Molecular Mechanisms for the Vicious Cycle between Insulin Resistance and the Inflammatory Response in Obesity.Int J Mol Sci. 2023 Jun 6;24(12):9818. doi: 10.3390/ijms24129818. Int J Mol Sci. 2023. PMID: 37372966 Free PMC article. Review.
-
Phosphorylation-Dependent Regulation of WNT/Beta-Catenin Signaling.Front Oncol. 2022 Mar 14;12:858782. doi: 10.3389/fonc.2022.858782. eCollection 2022. Front Oncol. 2022. PMID: 35359365 Free PMC article. Review.
-
Controlled Signaling-Insulin-Like Growth Factor Receptor Endocytosis and Presence at Intracellular Compartments.Front Endocrinol (Lausanne). 2021 Jan 29;11:620013. doi: 10.3389/fendo.2020.620013. eCollection 2020. Front Endocrinol (Lausanne). 2021. PMID: 33584548 Free PMC article. Review.
-
Insulin Substrate Receptor (IRS) proteins in normal and malignant hematopoiesis.Clinics (Sao Paulo). 2018 Oct 11;73(suppl 1):e566s. doi: 10.6061/clinics/2018/e566s. Clinics (Sao Paulo). 2018. PMID: 30328953 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
